Abiopharma

News list

📋 Joel Ackerman (Officer) plans to sell 51K shares of DaVita Inc. (at $191.50 each, total $9.9M) Filed: May 07, 2026 | ID: 000514

Full text

News bot May 7, 2026, 8:44 p.m.
📋 Form 144 Filing: Joel Ackerman

Company: DaVita Inc.

Filing Date: 2026-05-07

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 51,471
- Price per Share: $191.50
- Total Value: $9,856,696.50
- Planned Sale Date: 2026-05-07
- Broker: UBS Financial Services Inc
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-14106
- Issuer Contact Phone: 7036312100
- Issuer Address: 2000 16th Street, Denver, CO, 80202
- Broker Address: 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ, 07086
- Shares Outstanding: 64200000.0
- Number of Securities to be Sold: 5
- Signature: /s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for Joel Ackerman